Perbedaan Diagnos Laboratorium Utama Tbk. dan Lippo Karawaci Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,5 rb), sedangkan Lippo Karawaci Tbk. diperdagangkan di Rp62 (kapitalisasi pasar 4,47 T, volume 24 jam 122,37 jt). Perbedaan utamanya: Lippo Karawaci Tbk. jauh lebih besar — sekitar 14,1× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Lippo Karawaci Tbk. lebih aktif diperdagangkan (122,37 jt vs 41,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | LPKR | |
|---|---|---|
Kapitalisasi Pasar | 316,25 M | 4,47 T |
Volume | 41,5 rb | 122,37 jt |
Lot | 415 | 1,22 jt |
Perputaran | 9,61 jt | 7,61 M |
Harga Rata-rata | 231,65 | 62,21 |
Nilai Transaksi | 9,61 jt | 7,61 M |
Harga Ekuilibrium Indikatif | 230 | 64 |
Volume Ekuilibrium Indikatif | 2,4 rb | 7,4 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Selengkapnya di halaman LPKR →